Just to clarify what I was saying...
USP Forms Working Group on HPLC Column
The United States Pharmacopeia (USP) is pleased to announce that it has formed a USP Working Group on HPLC Columns. The group, which consists of members from the USP Expert Committee on Pharmaceutical Analysis 2, the National Institute of Standards and Technology (NIST), and major column manufacturers, is charged with creating categories in order to subclassify the USP designation L1 for C18 (octadecyl silane) HPLC columns. The subclassification of the L1 columns is meant to help facilitate the selection of alternative columns to be used for tests in accordance with the United States Pharmacopeia and National Formulary (USP-NF) monographs. The working group is starting with the L1 category due to the large number of columns within this classification and plans to extend its work to other column categories in the future.
"The group was created to help users of USP monographs simplify their column selections," said Margareth Marques, USP scientist and working group coordinator. "More than 220 HPLC columns can be classified as L1 for use with USP monographs, and this makes it difficult for an analyst to chose the proper column to use. USP wants to help column users streamline their processes and find alternative column choices."
The working group has decided to use NIST Standard Reference Material 870 to create the subclassifications. They will examine four characteristics (hydrophobicity, chelating, silanol activity, and shape selectivity) for each column, and the results from this study will be used to develop the subclassification criteria.
By this fall, the working group plans to have the necessary data to subclassify the L1 (C18) columns. For further information about the working group, please contact Margareth Marques, scientist at USP, at 301-816-8106 or e-mail her at
mrm@usp.org.